The University of Toledo

Center for Clinical Research : Active GYN protocols         Study number links to NCI protocol site

Skip to menu | Skip to content | Skip to search | Skip to global navigation
  • Home
  • About UT
  • Directions/Maps
  • Campus Directory
  • Contact
  • myUT
  • Advanced Search
  • Text Only
  • Feedback
  • Prospective Students
  • Admission
  • Academics
  • Campus Life
  • Current Students
  • Faculty & Staff
  • Research
  • Athletics
  • Alumni & Community
  • Print
Center for Clinical Research
  • No top menu
    • <!-- no script -->
    Select an Organ Site
    • Brain
    • Breast
    • Genitourinary
    • GI
    • GYN
    • Hematology
    • Melanoma
    • Cooperative Groups
    Generic
    no links

    Active GYN protocols         Study number links to NCI protocol site

    Endometrial

    • GOG-0209 - Phase III Randomized Study of Doxorubicin, Cisplatin, Paclitaxel, and Filgrastim (G-CSF) Versus Carboplatin and Paclitaxel in Patients With Stage III or IV or Recurrent Endometrial Cancer

    Ovarian

    • GOG 0218-Phase III Randomized Study of Carboplatin and Paclitaxel Versus Carboplatin, Paclitaxel, and Concurrent Bevacizumab With Versus Without Extended Bevacizumab in Patients With Stage III or IV Ovarian Epithelial or Primary Peritoneal Cancer

    Page updated: February 23, 2008
    Page top
    • Prospective Students
    • Admission
    • Academics
    • Campus Life
    • Current Students
    • Faculty & Staff
    • Research
    • Athletics
    • Alumni & Community
    The University of Toledo • 2801 W. Bancroft • Toledo, OH 43606-3390 • 1.800.586.5336
    © 2006-2008 The University of Toledo. All rights reserved. • Send all feedback / comments to webmaster.
    • Terms of Use